Cortical remyelination: A new target for repair therapies in multiple sclerosis

Annals of Neurology

Volumn 72, Issue 6, 2012, Pages 918-926

  Chang, Ansi ^a   Staugaitis, Susan M ^a   Dutta, Ranjan ^a   Batt, Courtney E ^a   Easley, Kathryn E ^a   Chomyk, Anthony M ^a   Yong, V Wee ^b   Fox, Robert J ^a   Kidd, Grahame J ^a   Trapp, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN TISSUE; CLINICAL ARTICLE; CORTICAL REMYELINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEURAL STEM CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; WHITE MATTER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ADULT STEM CELLS; AGED; ANTIGENS; ANTIGENS, CD44; CEREBRAL CORTEX; DEMYELINATING DISEASES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; POSTMORTEM CHANGES; PROTEOGLYCANS; REGENERATION; RNA, MESSENGER;

EID: 84871980802     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23693     Document Type: Article

References (41)

1. Noseworthy, JH, Lucchinetti, C, Rodriguez, M, et al. Multiple sclerosis. N Engl J Med 2000; 343: 938-952.
2. Love S, Louis D, Ellison D,. Greenfield's Neuropathology. 8th ed. London, UK: Oxford University Press, 2008.
3. Goodin, DS,. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment? Ann Neurol 2006; 59: 597-605.
4. Kidd D, Barkhof F, McConnell R, et al. Cortical lesions in multiple sclerosis. Brain 1999; 122: 17-26. (Pubitemid 29046269)
5. Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons and reduced inflammation in cortical MS lesions. Ann Neurol 2001; 50: 389-400. (Pubitemid 32848742)
6. Bo L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62: 723-732. (Pubitemid 36870458)
7. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712. (Pubitemid 41552953)
8. Vercellino M, Plano F, Votta B, et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 1101-1107.
9. Gilmore CP, Donaldson I, Bo L, et al. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009; 80: 182-187.
10. Kutzelnigg A, Lassmann H,. Cortical lesions and brain atrophy in MS. J Neurol Sci 2005; 233: 55-59. (Pubitemid 40804816)
11. Rudick RA, Lee JC, Nakamura K, et al. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 2009; 282: 106-111.
12. Franklin RJ, ffrench-Constant C,. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008; 9: 839-855.
13. Prineas JW, Barnard RO, Kwon EE, et al. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33: 137-151. (Pubitemid 23039922)
14. Raine CS, Wu E,. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 1993; 52: 199-204. (Pubitemid 23136018)
15. Lucchinetti C, Bruck W, Parisi J, et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999; 122: 2279-2295.
16. Prineas JW, Connell F,. Remyelination in multiple sclerosis. Ann Neurol 1979; 5: 22-31. (Pubitemid 9083248)
17. Chang A, Tourtellotte WW, Rudick R, et al. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002; 346: 165-173. (Pubitemid 34438882)
18. Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006; 129: 3165-3172. (Pubitemid 44871433)
19. Patani R, Balaratnam M, Vora A, et al. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 2007; 33: 277-287. (Pubitemid 46701044)
20. Goldschmidt T, Antel J, Konig FB, et al. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009; 72: 1914-1921.
21. Chang A, Nishiyama A, Peterson J, et al. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000; 20: 6404-6412.
22. Kuhlmann T, Miron V, Cuo Q, et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008; 131: 1749-1758. (Pubitemid 351957453)
23. Shen S, Sandoval J, Swiss VA, et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 2008; 11: 1024-1034.
24. Mi S, Miller RH, Lee X, et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005; 8: 745-751. (Pubitemid 43085840)
25. Charles P, Reynolds R, Seilhean D, et al. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 2002; 125: 1972-1979.
26. Back SA, Tuohy TM, Chen H, et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 2005; 11: 966-972. (Pubitemid 41294442)
27. Rist JM, Franklin RJ,. Taking ageing into account in remyelination-based therapies for multiple sclerosis. J Neurol Sci 2008; 274: 64-67.
28. Sherman LS, Back SA,. A 'GAG' reflex prevents repair of the damaged CNS. Trends Neurosci 2008; 31: 44-52.
29. Ponta H, Sherman L, Herrlich PA,. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003; 4: 33-45. (Pubitemid 36077255)
30. Sloane JA, Batt C, Ma Y, et al. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A 2010; 107: 11555-11560.
31. Trapp BD, Stys PK,. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009; 8: 280-291.
32. Irvine KA, Blakemore WF,. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008; 131: 1464-1477. (Pubitemid 351806463)
33. Staugaitis SM, Trapp BD,. NG2-positive glia in the human central nervous system. Neuron Glia Biol 2009; 5: 35-44.
34. Bo L, Mork S, Kong PA, et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994; 51: 135-146. (Pubitemid 24147480)
35. Dutta R, Chang A, Doud MK, et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol 2011; 69: 445-454.
36. Trapp BD, Nishiyama A, Cheng D, et al. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 1997; 137: 459-468. (Pubitemid 27181297)
37. Salzer JL,. Polarized domains of myelinated axons. Neuron 2003; 40: 297-318. (Pubitemid 37244097)
38. Bramow S, Frischer JM, Lassmann H, et al. Demyelination versus remyelination in progressive multiple sclerosis. Brain 2010; 133: 2983-2998.
39. Albert M, Antel J, Bruck W, et al. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 2007; 17: 129-138. (Pubitemid 46466131)
40. Hulst HE, Geurts JJ,. Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurol 2011; 11: 153.
41. Busch SA, Silver J,. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol 2007; 17: 120-127. (Pubitemid 46227979)